Taichung Veterans General Hospital
OrganisationROR
Trials
Phase 2, Completed, 39 people
Collaborator, Phase 1, Not yet recruiting, 44 people, 24 Aug 2026
Early phase 1, Not yet recruiting, 30 people, 6 Mar 2026
Phase 4, Recruiting, 50 people, 2 Sept 2025
Phase 4, Not yet recruiting, 150 people, 5 Mar 2025
Phase 3, Status unknown, 80 people, 4 Mar 2024
Phase 4, Active, not recruiting, 52 people, 8 Jun 2022
Collaborator, Phase 2, Active, not recruiting, 66 people, 30 Aug 2021
Collaborator, Phase 4, Completed, 28 people, 17 Dec 2020
Phase 4, Recruiting, 140 people, 1 May 2019
Phase 2, Terminated, 34 people, 7 Sept 2017
Collaborator, Phase 4, Active, not recruiting, 240 people, 19 Jan 2017
Phase 4, Status unknown, 500 people, 30 Dec 2016
Phase 3, Status unknown, 54 people, 17 Jul 2015
Collaborator, Phase 3, Terminated, 10 people, 16 Feb 2015
Collaborator, Phase 4, Completed, 20 people, 6 Nov 2014
Phase 3, Status unknown, 60 people, 4 Nov 2014
Collaborator, Phase 4, Completed, 40 people, 28 Feb 2014
Phase 2/3, Completed, 71 people, 17 Oct 2013
Phase 3, Terminated, 320 people, 7 Jun 2013
Sources: clinicaltrials.gov
Funded papers
TCVGH-1103602C, TCVGH-1103601D, TCVGH-1113602D, TCVGH-1123603C, 26 Aug 2026
TCVGH-NCHU1137624, TCVGH-NCHU1137625, TCVGH-1138202C, TCVGH-NCHU1127616, TCVGH-1144902C, TCVGH-NCHU1110114, 3 Nov 2025
Sources: api.crossref.org
Papers
Frontiers in immunology, 1 Sept 2026
Human reproduction open, 21 Aug 2026